• Maternal HBV prophylaxis does not affect BMD

    One year ago - By Healio

    Children of women who used tenofovir disoproxil fumarate, or TDF, to prevent transmission of hepatitis B to their child did not have lower bone mineral density compared with children who were exposed to placebo, according to findings from a randomized controlled trial published in Clinical Infectious Diseases.
    “TDF is often part of drug combinations that HIV-infected pregnant women take for their own health and the prevention of perinatal HIV transmission,” study researcher Gonzague Jourdain, MD, PhD, from the French National Research Institute for Sustainable Development, told
    Read more ...